PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
25-Nov-2024 Innovative Trials celebrates initiative success with industry peers at 2024 PMEA Awards Innovative Trials
25-Nov-2024 iiCON supports new phase II trial of novel pneumococcal vaccine, PnuBioVax iiCON
25-Nov-2024 Wellstack Partners With Hartford HealthCare to Advance Data Integration and Healthcare Analytics AccessWire
25-Nov-2024 Jaguar Health Presenting December 3rd at NobleCon20 and December 5th at the Emerging Growth Conference AccessWire
25-Nov-2024 CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy AccessWire
25-Nov-2024 Neurotech Innovator UNEEG Medical Receives FDA Breakthrough Device Designation Within Monitoring and Diagnostic of Epilepsy AccessWire
25-Nov-2024 MRES: Dr. Esmarilda Dankaert Appointed Chief Innovation Officer (CINO) at M2Bio Sciences AccessWire
25-Nov-2024 Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled AccessWire
25-Nov-2024 TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell Carcinoma and Provides Business Update AccessWire
25-Nov-2024 InTheZone Labs Progresses Towards Amazon Listing, Expands Affiliate Program, and Shares Promising Phase One Testing Updates Newswire
25-Nov-2024 Doron Therapeutics Raises $11M Series A to Progress Biologic Regenerative Osteoarthritis Drug into Phase 3 Clinical Studies Newswire
25-Nov-2024 Doron Therapeutics Raises $11M Series A to Progress Biologic Regenerative Osteoarthritis Drug into Phase 3 Clinical Studies AccessWire
25-Nov-2024 Acreage Provides Update on Corporate Transactions AccessWire
25-Nov-2024 Moderna to Present at Upcoming Conferences in December 2024 AccessWire
25-Nov-2024 Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price Manipulation AccessWire
25-Nov-2024 Coulter Partners secures industry-leading Chief Medical Officer for Solu Therapeutics Coulter Partners
25-Nov-2024 SYNBIOTIC integrates greensby: Universal platform for the entire hemp and cannabis industry SYNBIOTIC SE
25-Nov-2024 BioNxt Announces Enhanced Sublingual Product Development Pipeline with Innovative Solutions for Autoimmune Diseases and Longevity AccessWire
22-Nov-2024 Comment on withdrawn non-binding offer Evotec SE
22-Nov-2024 Eckert & Ziegler raises its forecast for the current financial year once again Eckert & Ziegler SE